Characterization of initiation of angiogenesis in early stages of prostate adenocarcinoma development and progression in a transgenic murine model

Urology

Volumn 64, Issue 6, 2004, Pages 1233-1237

  Gabril, Manal ^a   Xuan, Jim ^a   Moussa, Madeleine ^a   Dinney, Colin P N ^c   Chin, Joseph L ^a,b   Izawa, Jonathan I ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; MESSENGER RNA; PROTEIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CONTROLLED STUDY; DENSITY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROTEIN DETERMINATION; PROTEIN EXPRESSION; TISSUE DIFFERENTIATION; TRANSGENIC MOUSE;

ADENOCARCINOMA; ANIMALS; FIBROBLAST GROWTH FACTOR 2; MALE; MICE; MICE, TRANSGENIC; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; PROSTATIC NEOPLASMS; PROSTATIC SECRETORY PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 10644292399     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2004.07.034     Document Type: Article

References (19)

1. J. Folkman, K. Watson, D. Ingber Induction of angiogenesis during the transition from hyperplasia to neoplasia Nature 339 1989 58 61
2. G.F. Greene, Y. Kitadai, C.A. Pettaway Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique Am J Pathol 150 1997 1571 1582
3. J.I. Izawa, C.P.N. Dinney The role of angiogenesis in prostate and other urologic cancers a review Can Med Assoc J 164 2001 662 670
4. D. Hanahan, J. Folkman Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86 1996 353 364
5. H.B. Carter, S. Piantadosi, J.T. Isaacs Clinical evidence for and implications of the multistep development of prostate cancer J Urol 143 1990 742 746
6. P.T. Scardino, R. Weaver, M.A. Hudson Early detection of prostate cancer Hum Pathol 23 1992 211 222
7. I.B. Joseph, J. Vukanovic, J.T. Isaacs Antiangiogenic treatment with linomide as chemoprevention for prostate, seminal vesicle, and breast carcinogenesis in rodents Cancer Res 56 1996 3404 3408
8. M.Y. Gabril, T. Ontia, P.G. Ji Prostate targeting PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model Gene Ther 9 2002 1589 1599
9. J.M. Arbeit, D. Olson, D. Hanahan Upregulation of fibroblast growth factors and their receptors during multistage epidermal carcinogenesis in K14-HPV16 transgenic mice Oncogene 13 1996 1847 1857
10. W.J. Huss, C.F. Hanrahan, R.J. Barrios Angiogenesis and prostate cancer identification of a molecular progression switch Cancer Res 61 2001 2736 2743
11. J. Yoneda, H. Kuniyasu, M.A. Crispens Expression of angiogenesis-related genes and progression of human ovarian carcinoma in nude mice J Natl Cancer Inst 90 1998 447 454
12. L.D. Fisher, G. van Belle Biostatistics 1993 John Wiley & Sons New York pp 786-843
13. J.A. Doll, F.K. Reiher, S.E. Crawford Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate Prostate 49 2001 293 305
14. S.F. Huang, S.J. Kim, A.T. Lee Inhibition of growth and metastasis of orthotopic human prostate cancer in athymic mice by combination therapy with pegylated interferon-alpha-2b and docetaxel Cancer Res 62 2002 5720 5726
15. K. Walsh, R.A. Sherwood, T.K. Dew Angiogenic peptides in prostatic disease BJU Int 84 1999 1081 1083
16. S. Soker, M. Kaefer, M. Johnson Vascular endothelial growth factor-mediated autocrine stimulation of prostate tumor cells coincides with progression to a malignant phenotype Am J Pathol 159 2001 651 659
17. S. Haggstrom, A. Bergh, J.E. Damber Vascular endothelial growth factor content in metastasizing and nonmetastasizing Dunning prostatic adenocarcinoma Prostate 45 2000 42 50
18. W.D. Fox, B. Higgins, K.M. Maiese Antibody to vascular endothelial growth factor slows growth of an androgen-independent xenograft model of prostate cancer Clin Cancer Res 8 2002 3226 3231
19. P. Sweeney, T. Karashima, S.J. Kim Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production Clin Cancer Res 8 2002 2714 2724